Target Hemoglobin May Be Achieved with Intravenous Iron Alone in Anemic Patients with Cardiorenal Syndrome: An Observational Study

BACKGROUND: The treatment of anemia in patients with cardiorenal syndrome (CRS) is based mainly on intravenous (IV) iron therapy and/or erythropoiesis-stimulating agents (ESAs). There are concerns about the safety of ESAs due to a potentially higher risk for stroke and malignancy. OBJECTIVE: We aime...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiorenal Med
Main Authors: Ben-Assa, Eyal, Shacham, Yacov, Shashar, Moshe, Leshem-Rubinow, Eran, Gal-Oz, Amir, Schwartz, Idit F., Schwartz, Doron, Silverberg, Donald S., Chernin, Gil
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2015
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4662275/
https://ncbi.nlm.nih.gov/pubmed/26648941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000433564
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados